Elutia (ELUT)

Profile

Full Name

Elutia Inc.

Ticker Symbol

ELUT

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

October 8, 2020

Indexes

Not included

Website

http://elutia.com

Employees

51

Key Details

Price

$2.17(-5.24%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$24.38M(-1.50% YoY)

Annual EPS

-$1.86(+10.14% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.17
ELUT price is $2.17

30-Day Relative Volume

0.48
ELUT 30-day relative volume is 0.48

Price Performance

Price Most recent change

-5.24%
ELUT price was down -5.24% on Apr 24, 2025

Price YTD change

-41.98%
ELUT price is down -41.98% since January 1st

Price 1-year change

-24.91%
ELUT price is down -24.91% year-on-year

Price 3-year change

-66.97%
ELUT price is down -66.97% over the past 3 years

Price Range

Price All-time high

$18.20
ELUT price is currently -88.08% below its historical high of $18.20

Price 3-year low

$1.10
ELUT price is currently +97.27% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$88.68M
ELUT market capitalization is $88.68 million

Market cap 3-year change

-0.9%
ELUT market capitalization is down -0.9% over the past 3 years

Market cap All-time high

$167.81M
ELUT market capitalization is currently -47.16% below its historical high of $167.81 million

Market cap sector rank

45.07%
ELUT market capitalization is higher than 45.07% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+67.83%
ELUT shares outstanding is up +67.83% year-on-year

Shares Outstanding 3-Year Change

+200.04%
ELUT shares outstanding is up +200.04% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.79
ELUT beta is 0.79

200-day SMA

$3.48
ELUT price is currently -37.71% below its 200-day simple moving average

50-day SMA

$2.78
ELUT price is currently -21.97% below its 50-day simple moving average

RSI

38.75
ELUT 14-day relative strength index is 38.75

Volume

0.48
ELUT 30-day relative volume is 0.48

ATR

$0.26
ELUT average true range is $0.26

10-day Historical Volatility

97.05%
ELUT 10-day historical volatility is 97.05%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$24.38M
ELUT annual revenue is $24.38 million

Revenue Analysts estimate

$33.30M
ELUT annual revenue is currently -26.80% lower than the consensus analysts' forecast

Revenue 1-year change

-1.5%
ELUT annual revenue is down -1.5% year-on-year

Revenue Sector rank

35.95%
ELUT annual revenue is higher than 35.95% of companies in Healthcare sector

EPS

EPS

-$1.86
ELUT annual earnings per share is -$1.86

EPS Analysts estimate

-
ELUT annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+10.14%
ELUT annual earnings per share is up +10.14% year-on-year

EPS Sector rank

39.65%
ELUT annual earnings per share is higher than 39.65% of companies in Healthcare sector

Profit

Gross profit

$10.71M
ELUT annual gross profit is $10.71 million

Gross margin

43.93%
ELUT annual gross profit margin is 43.93%

Operating profit

-$24.28M
ELUT annual operating income is -$24.28 million

Operating margin

-99.62%
ELUT annual operating profit margin is -99.62%

Net income

-$53.95M
ELUT annual net profit is -$53.95 million

Net margin

-221.33%
ELUT annual net profit margin is -221.33%

Expenses

Total expenses

$48.66M
ELUT annual total expenses is $48.66 million

Operating expenses

$34.99M
ELUT annual total operating expenses is $34.99 million

Cost of goods sold

$13.67M
ELUT annual cost of goods sold is $13.67 million

Selling, general & administrative expenses

$31.20M
ELUT annual SGA is $31.20 million

Depreciation and amortization

$3.45M
ELUT annual depreciation & amortization is $3.45 million

Interest expense

$4.78M
ELUT annual interest expense is $4.78 million

Income tax

$7000.00
ELUT annual income tax is $7000.00

EBIT & EBITDA

EBIT

-$49.34M
ELUT annual earnings before interest & taxes is -$49.34 million

EBITDA

-$49.34M
ELUT annual EBITDA is -$49.34 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$36.13M
ELUT annual total assets is $36.13 million

Non current assets

$9.96M
ELUT annual long term assets is $9.96 million

Current assets

$26.17M
ELUT annual total current assets is $26.17 million

Cash and cash equivalents

$13.24M
ELUT annual cash & cash equivalents is $13.24 million

Accounts receivable

$2.28M
ELUT annual accounts receivable is $2.28 million

Inventory

$3.91M
ELUT annual inventory is $3.91 million

Liabilities

Total liabilities

$82.39M
ELUT annual total liabilities is $82.39 million

Long term liabilities

$44.59M
ELUT annual total long term liabilities is $44.59 million

Current liabilities

$37.80M
ELUT annual total current liabilities is $37.80 million

Accounts payable

$11.25M
ELUT annual accounts payable is $11.25 million

Debt

Total debt

$24.31M
ELUT annual total debt is $24.31 million

Total debt 1-year change

+1.51%
ELUT annual total debt is up +1.51% year-on-year

Long term debt

$22.60M
ELUT annual long term debt is $22.60 million

Short term debt

$1.71M
ELUT annual short term debt is $1.71 million

Equity & Capital

Shareholders equity

-$46.26M
ELUT annual stockholders equity is -$46.26 million

Book value

-$46.26M
ELUT annual book value is -$46.26 million

Retained earnings

-$229.59M
ELUT annual retained earnings is -$229.59 million

Working capital

-$11.62M
ELUT annual working capital is -$11.62 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$22.66M
ELUT annual cash flow from operations is -$22.66 million

Cash from operations 1-year change

-4.12%
ELUT annual cash flow from operations is down -4.12% year-on-year

Cash from investing

-$474.00K
ELUT annual cash flow from investing activities is -$474.00 thousand

Cash from investing 1-year change

-103.34%
ELUT annual cash flow from investing activities is down -103.34% year-on-year

Cash from financing

$17.09M
ELUT annual cash flow from financing activities is $17.09 million

Cash from financing 1-year change

+73.72%
ELUT annual cash flow from financing activities is up +73.72% year-on-year

CAPEX

CAPEX

$654.00K
ELUT annual capital expenditures is $654.00 thousand

CAPEX 1-year change

+89.02%
ELUT annual capital expenditures is up +89.02% year-on-year

Free Cash Flow

Free cash flow

-$23.31M
ELUT annual free cash flow is -$23.31 million

Free cash flow 1-year change

-5.45%
ELUT annual free cash flow is down -5.45% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

43.93%
ELUT annual gross profit margin is 43.93%

Operating margin

-99.62%
ELUT annual operating profit margin is -99.62%

Net margin

-221.33%
ELUT annual net profit margin is -221.33%

ROA & ROE

ROA

-135.63%
ELUT annual return on assets is -135.63%

ROE

116.62%
ELUT annual return on equity is 116.62%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ELUT price to earnings ratio value is unknown

PE ratio Sector rank

-
ELUT price to earnings ratio is unknown

PB Ratio

PB ratio

-1.92
ELUT price to book ratio is -1.92

PB ratio Sector rank

6.8%
ELUT price to book ratio is higher than 6.8% of companies in Healthcare sector

PS Ratio

PS ratio

3.64
ELUT price to sales ratio is 3.64

PS ratio Sector rank

56.23%
ELUT price to sales ratio is higher than 56.23% of companies in Healthcare sector

Enterprise value

Enterprise value

$100.18M
ELUT enterprise value is $100.18 million

Enterprise value Sector rank

48.54%
ELUT enterprise value is higher than 48.54% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.14
ELUT EV/EBITDA is -2.14

EV/EBITDA Sector rank

33.6%
ELUT EV/EBITDA is higher than 33.6% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.69
ELUT annual current ratio is 0.69

Quick ratio

0.59
ELUT annual quick ratio is 0.59

Leverage

Debt to equity

-0.52
ELUT annual debt to equity ratio is -0.52

Interest coverage ratio

-10.32
ELUT annual interest coverage ratio is -10.32

Risk & Stability

Piotroski F-Score

3
ELUT piotroski f-score is 3

Altman Z-Score

-12.47
ELUT altman z-score is -12.47

Analyst ratings

Recent major analysts updates

Mar 7, 25 Cantor Fitzgerald
Overweight
Nov 15, 24 Cantor Fitzgerald
Overweight
Sep 6, 24 Cantor Fitzgerald
Overweight
Aug 8, 24 Cantor Fitzgerald
Overweight
Jun 21, 24 Lake Street
Buy
Jun 20, 24 Cantor Fitzgerald
Overweight
Jun 18, 24 Cantor Fitzgerald
Overweight
May 10, 24 Cantor Fitzgerald
Overweight
Nov 14, 23 Cantor Fitzgerald
Overweight
Sep 28, 23 Lake Street
Buy

Institutional Ownership

Similar stocks

IFRX logo
InflaRx NV (IFRX)
CRDL logo
Cardiol Therapeutics (CRDL)
VTYX logo
Ventyx Biosciences (VTYX)
Climb Bio (CLYM)
CNTX logo
Context Therapeutics (CNTX)
GALT logo
Galectin Therapeutics (GALT)
NAUT logo
Nautilus Biotechnology (NAUT)
XBIT logo
XBiotech (XBIT)
ICAD logo
iCAD (ICAD)
  • What is the ticker symbol for Elutia?
  • Does Elutia pay dividends?
  • What sector is Elutia in?
  • What industry is Elutia in?
  • What country is Elutia based in?
  • When did Elutia go public?
  • Is Elutia in the S&P 500?
  • Is Elutia in the NASDAQ 100?
  • Is Elutia in the Dow Jones?
  • When was Elutia's last earnings report?
  • When does Elutia report earnings?
  • Should I buy Elutia stock now?

What is the ticker symbol for Elutia?

The ticker symbol for Elutia is NASDAQ:ELUT

Does Elutia pay dividends?

No, Elutia does not pay dividends

What sector is Elutia in?

Elutia is in the Healthcare sector

What industry is Elutia in?

Elutia is in the Medical Devices industry

What country is Elutia based in?

Elutia is headquartered in United States

When did Elutia go public?

Elutia's initial public offering (IPO) was on October 8, 2020

Is Elutia in the S&P 500?

No, Elutia is not included in the S&P 500 index

Is Elutia in the NASDAQ 100?

No, Elutia is not included in the NASDAQ 100 index

Is Elutia in the Dow Jones?

No, Elutia is not included in the Dow Jones index

When was Elutia's last earnings report?

Elutia's most recent earnings report was on Mar 6, 2025

When does Elutia report earnings?

The next expected earnings date for Elutia is May 9, 2025

Should I buy Elutia stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page